Clinical Trials in Ohio

Showing 13661-13680 of 20,938 trials

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

NCT01715012

This study is a randomized, double blind, placebo controlled trial at a single site. The primary objective is to evaluate the safety of ST266 in diabetic subjects with deep burns. The secondary objectives of this study are to (1) evaluate efficacy of ST266 in healing burns and (2) evaluate whether treatment with ST266 results in less scarring, in subjects with diabetes separately comparing healing of the skin graft and the skin graft donor site using ST266 plus a burn dressing versus placebo and a burn dressing.

Third Degree BurnsDiabetes

Noveome Biotherapeutics, formerly Stemnion1 participantsStarted Oct 2012

Columbus, Ohio, United States

COMPLETEDPhase 132 miles

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

NCT03127735

To determine the maximum tolerated and / or recommended Phase II dose of oral mutant IDH1 (mIDH1) inhibitor BAY1436032 and to characterize its safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy in patients with mIDH1-R132X advanced acute myeloid leukemia (AML)

Leukemia, Myeloid, Acute

Bayer27 participantsStarted Jun 2017

Buffalo, New York, United States • New York, New York, United States • The Bronx, New York, United States +10 more locations

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Find Trials by Condition in Ohio

The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

ST266 Versus Standard Care In Treating Partial Thickness Burns

The Chimerix CMX001 Registry

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)

A Study for Patients With Acute Leukemia

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

The PROOF Study: The PICC Related Obstruction Of Flow Study

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Fenzian Asthma Multicenter Outcomes Study

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma